Scholars Central

Conference abstractPublished 2015

Human amniotic membrane: An option to the treatment of Achilles tendon induced tendinopathy

Authors: Luciana Barros Sant’Anna, Mariana de Castro Nicodemo, Lia Renó das Neves, Josafa Carvalho Aguiar, Flaviane de Souza Brito, Isabelle Ferreira, Leandro José Raniero, Paulo RoxoBarja, Emilia Angela Loschiavo Arisawa

University of Paraíba Valley, Brazil

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Human placenta at term which is usually discarded as medical waste has attracted much attention as a source of tissues and stem/progenitor cells for research and potential clinical applications. The anti-inflammatory, anti-scarring and wound healing properties of amniotic membrane (AM) could make her useful for development of new therapeutic approaches in regenerative medicine and warrant studies of their effects in animal models of inflammatory and fibrotic pathologies. Biliary fibrosis and resultant cirrhosis are among the most common outcome of chronic liver disease. Currently, liver transplantation remains the only effective treatment. Here, we investigated if the intact hAM has the capacity to reduce a well-established liver fibrosis induced in rat by bile duct ligation (BDL) model. After 2 weeks from BDL, the liver was covered with a fragment of hAM or left untreated. Six weeks later, the fibrosis was first assessed by semi-quantitative scoring systems and by Cell Profiler digital image analysis to quantify the area occupied by ductular reaction, activated myofibroblasts, collagen deposition and by transforming growth factor (TGF)-1, the main profibrogenic factor in chronic liver disease. After 6 weeks of BDL, AM rats showed a significant reduction in the severity of fibrosis. The amount of collagen deposition, the ductular reaction and the myofibroblasts were all reduced to about 50% of levels observed in BDL rats. AM was able to markedly attenuated TGF-1 immunoexpression in liver. These findings suggest that hAM patching is useful for treating cholestatic fibrosis and the mechanism was partly by reduction in the TGF-1expression.

Subjects

Engineering

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Regenerative Medicine
  • SubjectEngineering
  • BylineArticles whose byline prints “Luciana Barros Sant’Anna”
  • BylineArticles whose byline prints “Mariana de Castro Nicodemo”
  • BylineArticles whose byline prints “Lia Renó das Neves”
  • BylineArticles whose byline prints “Josafa Carvalho Aguiar”
  • BylineArticles whose byline prints “Flaviane de Souza Brito”
  • BylineArticles whose byline prints “Isabelle Ferreira”
  • BylineArticles whose byline prints “Leandro José Raniero”
  • BylineArticles whose byline prints “Paulo RoxoBarja”